- Home
- IAS vs SLNO Comparison
IAS vs SLNO Comparison
Compare IAS & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IAS
- SLNO
- Stock Information
- Founded
- IAS 2009
- SLNO 1999
- Country
- IAS United States
- SLNO United States
- Employees
- IAS N/A
- SLNO N/A
- Industry
- IAS Computer Software: Programming Data Processing
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- IAS Technology
- SLNO Health Care
- Exchange
- IAS Nasdaq
- SLNO Nasdaq
- Market Cap
- IAS 1.7B
- SLNO 1.9B
- IPO Year
- IAS 2021
- SLNO 2014
- Fundamental
- Price
- IAS $11.20
- SLNO $54.63
- Analyst Decision
- IAS Buy
- SLNO Strong Buy
- Analyst Count
- IAS 11
- SLNO 7
- Target Price
- IAS $15.70
- SLNO $69.86
- AVG Volume (30 Days)
- IAS 1.4M
- SLNO 504.7K
- Earning Date
- IAS 11-12-2024
- SLNO 11-06-2024
- Dividend Yield
- IAS N/A
- SLNO N/A
- EPS Growth
- IAS 258.32
- SLNO N/A
- EPS
- IAS 0.20
- SLNO N/A
- Revenue
- IAS $511,358,000.00
- SLNO N/A
- Revenue This Year
- IAS $15.17
- SLNO N/A
- Revenue Next Year
- IAS $14.71
- SLNO N/A
- P/E Ratio
- IAS $57.03
- SLNO N/A
- Revenue Growth
- IAS 11.77
- SLNO N/A
- 52 Week Low
- IAS $7.98
- SLNO $26.38
- 52 Week High
- IAS $17.53
- SLNO $59.75
- Technical
- Relative Strength Index (RSI)
- IAS 49.08
- SLNO 51.30
- Support Level
- IAS $9.94
- SLNO $50.69
- Resistance Level
- IAS $12.86
- SLNO $59.75
- Average True Range (ATR)
- IAS 0.50
- SLNO 2.47
- MACD
- IAS -0.16
- SLNO -0.48
- Stochastic Oscillator
- IAS 34.24
- SLNO 43.47
About IAS Integral Ad Science Holding Corp.
Integral Ad Science Holding Corp is a digital advertising verification company. The cloud-based technology platform of the company delivers independent measurement and verification of digital advertising across all devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video. Geographically, the company derives a majority of its revenue from the Americas region.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.